Personalis

$27.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.53 (+5.83%) Today
-$0.52 (-1.88%) As of 5:13 AM EST after-hours

Why Robinhood?

You can buy or sell Personalis and other stocks, options, and ETFs commission-free!

About PSNL

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA. The listed name for PSNL is Personalis, Inc. Common Stock.

CEO
John S. West
Employees
182
Headquarters
Menlo Park, California
Founded
2011
Market Cap
1.08B
Price-Earnings Ratio
Dividend Yield
Average Volume
1.13M
High Today
$28.01
Low Today
$25.93
Open Price
$26.46
Volume
450.36K
52 Week High
$32.80
52 Week Low
$4.27

Collections

PSNL Earnings

-$0.89
-$0.59
-$0.30
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 25, After Hours

You May Also Like